Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

186.18

+1.44 (0.78%)

At close: Feb 19, 2026, 4:00 PM EST

187.49

+1.31 (0.71%)

After-hours: Feb 19, 2026, 7:50 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Developing and Delivering novel therapies for the management of CNS disorders	385.69M	270.60M	50.04M	-	-
Developing and Delivering novel therapies for the management of CNS disorders Growth	42.53%	440.80%	-	-	-
Total	385.69M	270.60M	50.04M	-	-
Total Growth	42.53%	440.80%	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States	378.16M	197.22M	49.13M	-	-
United States Growth	91.74%	301.42%	-	-	-
Outside of The United States	3.52M	5.24M	905.00K	-	-
Outside of The United States Growth	-32.81%	478.56%	-	-	-
Total	381.68M	202.46M	50.04M	-	-
Total Growth	88.52%	304.62%	-	-	-

Source: S&P Global Market Intelligence.